8 January 2020 · The below summary details the legal position regarding the sale, supply or administration of off-label/unlicensed products under Schedule 17 of the HMR 2012
22 February 2022 · Consideration needs to be given to the risk factors particularly associated with transcribing in non-acute settings with healthcare input
21 June 2021 · Moving vaccines within and between NHS organisations is subject to regulatory constraints. Senior pharmacists need to be able to advise on appropriate practice
9 September 2020 · This article provides advice on the legal considerations required when considering mixing medicines to be supplied or administered under a PGD
24 January 2022 · The main legal mechanisms used to supply and/or administer medicines are explained and considerations suggested for the most appropriate option(s)
9 September 2020 · Advice on the legal labelling requirements for Prescription Only Medicines (POM) and and Pharmacy Medicines (P) supplied under a PGD.
1 March 2022 · National guidance from NHSE/I to reduce LASA errors and improve patient safety when considering requirements for unlicensed specials medicines
5 December 2016 · This document is aimed at staff in UK NHS hospitals considering or already sourcing their supply of chemotherapy as ready-to-administer doses.